Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.35 |
| ▸ | MGAM | O43451 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | SI | P14410 | 1/20 | 0.33 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.32 |
| ▸ | MIF | P14174 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 2/20 | 0.31 |
| ▸ | MMP1 | P03956 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | MMP8 | P22894 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LTA4H | P09960 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16626822 | 0.85 | CA1 (0.48) | CA1CA2SMN1; SMN2ZDHHC7MGAM | |
| SCHEMBL14601911 | 0.85 | CA1 (0.48) | CA1CA2SMN1; SMN2ZDHHC7MGAM | |
| SCHEMBL30561836 | 0.81 | CA1 (0.42) | CA1CA2SMN1; SMN2ZDHHC7MGAM | |
| SCHEMBL5079956 | 0.81 | CA1 (0.42) | CA1CA2SMN1; SMN2ZDHHC7MGAM | |
| SCHEMBL18359202 | 0.81 | CA1 (0.42) | CA1CA2SMN1; SMN2ZDHHC7MGAM | |
| SCHEMBL13615011 | 0.79 | CA2 (0.55) | CA1CA2ZDHHC7ABCB1TSHR | |
| SCHEMBL7433060 | 0.78 | SMN1; SMN2 (0.46) | CA1CA2SMN1; SMN2ZDHHC7MGAM | |
| SCHEMBL2225324 | 0.78 | CA1 (0.43) | CA1CA2SMN1; SMN2ZDHHC7MGAM | |
| SCHEMBL12518959 | 0.78 | CA1 (0.43) | CA1CA2SMN1; SMN2ZDHHC7MGAM | |
| SCHEMBL13443753 | 0.78 | SMN1; SMN2 (0.46) | CA1CA2SMN1; SMN2ZDHHC7MGAM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080033154-A1 | Process for Producing 3-Aminomethyltetrahydrofuran Derivative | MITSUI CHEMICALS, INC. (JP) | 2008-02-07 | — | — | US | disclosed |
| CN-1968941-A | Method for producing 3-aminomethyltetrahydrofuran derivative | MITSUI CHEMICALS INC (JP) | 2007-05-23 | — | — | CN | disclosed |
| EP-1780205-A1 | METHOD FOR PRODUCING 3-AMINOMETHYLTETRAHYDROFURAN DERIVATIVE | Mitsui Chemicals, Inc. (JP) | 2007-05-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080033154-A1 | Process for Producing 3-Aminomethyltetrahydrofuran Derivative | ALAD, ACMSD, HPD | CA1 2777/4885CA2 1164/4885SMN1; SMN2 3517/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.